After more than a decade without major breakthroughs in anxiety medication, several promising treatments are now moving through clinical trials. These investigational options use new delivery systems, ...
After two notable failures, the social anxiety R&D space gained a major player when Eli Lilly agreed to acquire AtaiBeckley ...
LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned in the U.S. for ...
Pharmaceutical company Viatris Specialty LLC voluntarily recalled one lot of Xanax XR (alprazolam extended-release 3 mg) tablets on March 17, 2025, after routine quality testing revealed the pills ...
In the 1960s, major pharmaceutical companies began a concerted effort to find new and better treatments for problems related to fear and anxiety. However, new kinds of antianxiety medications have not ...
Xanax, a drug used to treat anxiety disorders, has been placed under a nationwide recall. Viatris, the maker of Xanax, recalled the medication last month because of "failed dissolution specifications, ...
Medications known as beta-blockers are the “chill pill” of the moment, an increasingly popular go-to for people hoping to stave off physical symptoms of anxiety — a racing heart, sweaty palms, ...
A reality TV star's claim that a beta blocker dulled their emotions and made them appear calm on camera has sparked a wave of social media commentary. These medicines, first developed to manage high ...
The study uncovered how the psychedelic drug DOI reduces anxiety by activating particular neurons in the brain. DOI’s anxiety-reducing properties do not coincide with its hallucinogenic effects, ...
A systematic review of 43 studies found highly heterogeneous results for GLP-1 receptor agonists across animal models and ...
3 mg tablets of the medication, sold in 60-tablet bottles, were initially recalled by its distributor, Viatris, on March 17. On April 15, the tablets were recalled nationwide The affected medication ...